Ticker Details
ImmunityBio, Inc. Common Stock
IPO Date:	July 27, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.26B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.92%
Avg Daily Range (30 D):	$0.25 | 3.27%
Avg Daily Range (90 D):	$0.24 | 3.18%

Institutional Daily Volume
Avg Daily Volume:	6.01M
Avg Daily Volume (30 D):	7.86M
Avg Daily Volume (90 D):	10.97M

Trade Size
Avg Trade Size (Sh.):	253
Avg Trade Size (Sh.) (30 D):	187
Avg Trade Size (Sh.) (90 D):	226

Institutional Trades
Total Institutional Trades:	2,143
Avg Institutional Trade:	$2.02M
Avg Institutional Trade (30 D):	$3.32M
Avg Institutional Trade (90 D):	$3.08M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.6M
Avg Closing Trade (30 D):	$5.55M
Avg Closing Trade (90 D):	$7.24M
Avg Closing Volume:	464.44K

News

May 26, 2026 @ 8:00 PM INVESTOR ALERT: Pomerantz Law Firm Reminds Investo... Source: Pomerantz Llp

May 25, 2026 @ 11:22 PM IBRX DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR... Source: Rosen Law Firm

May 25, 2026 @ 1:48 PM IBRX Investors Have Opportunity to Lead ImmunityBi... Source: The Schall Law Firm

May 22, 2026 @ 10:11 PM IBRX DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED I... Source: Rosen Law Firm

May 22, 2026 @ 4:48 PM IBRX 4-DAY DEADLINE ALERT: ImmunityBio (IBRX) Inve... Source: Hagens Berman

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.97	$-.22	$-.62
Diluted EPS	$-.97	$-.22	$-.62
Revenue	$165.79M	$51.24M	$44.21M
Gross Profit	$164.7M	$50.94M	$43.97M
Net Income / Loss	$-992.42M	$-230.39M	$-632.8M
Operating Income / Loss	$-251.8M	$-61.7M	$-69.79M
Cost of Revenue	$1.1M	$.3M	$.24M
Net Cash Flow	$-61.26M	$-129.52M	$116.92M
PE Ratio